Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
shop dildos - is great for every girl.
Popular Articles

Gene Transfer Technology May Lead To HIV Vaccine
A research team may have broken the impasse that has frustrated HIV vaccine researchers by using an unconventional approach that bypasses the usual vaccine development path. Using gene transfer technology to produces molecules that block infection, the scientists protected monkeys from infection by a virus closely related to HIV -- the simian immunodeficiency virus, or SIV. "We used a leapfrog strategy, bypassing the natural immune system response that was the target of previous HIV and SIV vaccine candidates," explains study leader Philip R. Johnson, MD, chief scientific officer at The Children"s Hospital of Philadelphia and professor of pediatrics at the University of Pennsylvania. Johnson and colleagues reported their work in Nature Medicine Most attempts at developing an HIV vaccine have used substances aimed at stimulating the body"s immune system to produce antibodies that would eliminate the virus before or after it infected cells. In clinical trials, however, these vaccines have not elicited protective immune responses, just as the body fails on its own to produce an effective response during natural HIV infection.
drugs without prescription
The Preclinical Natural History Of Serous Ovarian Cancer: Defining The Target For Early Detection
Ovarian cancer kills approximately 15,000 women in the United States every
News of the day
Study Finds Estrogen Receptor-Negative Tumors Have Vaccine Targets
A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor (ER). CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma. The study - to be published in the Early Edition of the Proceedings of the National Academy of Sciences this week - was led by the international Ludwig Institute for Cancer Research (LICR).
Health Insurance

Total Swine Flu A(H1N1) Human Infection Cases Reach 7,447 In The United Kingdom

The Health Protection Agency (HPA), UK, informed yesterday 3rd July, 2009, in its weekly update that the total number of confirmed human cases of Swine Flu A(H1N1) infection has reached 7,447. British health authorities estimate that the figure will be over 100,000 by the end of this summer. The UK government says that it is now moving to a new phase in the current pandemic response - there will be a change to the surveillance information that the HPA will be able to provide in future. To date, the HPA has been carrying out laboratory testing of suspected swine flu infection cases since the onset of the outbreak in April 2009. The HPA"s updates have been based on the total number of positive test results being confirmed through the Centre for Infections and the HPA"s regional network of laboratories. The new policy means that measures to try to contain the pandemic will move to providing suitable treatment to infected people. Nationally, clinicians will from now on rely on patients" signs and symptoms and not on laboratory tests to diagnose swine flu infection. Although a percentage of patients will be tested in order to gather up-to-date data about the virus, the reporting of laboratory confirmations will no longer be an accurate way to record the spread of infection. Total number of confirmed human infections of Swine Flu A(H1N1), 3rd June, 2009 *East of England - 411 *East Midlands - 147 *London - 1939 *North East - 47 *North West - 97 *South East - 598 *South West - 198 *West Midlands - 2582 *Yorkshire & Humber - 143 TOTAL ENGLAND - 6162 *Northern Ireland - 34 *Scotland - 1217 *Wales - 34 TOTAL UK - 7447 Written by Christian Nordqvist Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009